Minimum Alveolar Concentration of Isoflurane in Rats Chronically Treated with the Synthetic Cannabinoid WIN 55,212-2

Minimum Alveolar Concentration of Isoflurane in Rats Chronically Treated with the Synthetic Cannabinoid WIN 55,212-2

The minimum alveolar concentration MAC of isoflurane was measured in rats chronically treated with WIN 55,212-2. Methods: The MAC of isoflurane was determined in 24 male rats from expiratory samples at time of tail clamping under the following conditions: without treatment MAC(<sub>ISO</sub...

Full description

Bibliographic Details
Main Authors:	Julio Raul Chavez-Monteagudo, José Antonio Ibancovichi, Pedro Sanchez-Aparicio, Sergio Recillas-Morales, Jorge Osorio-Avalos, Marco Antonio De Paz-Campos
Format:	Article
Language:	English
Published:	MDPI AG 2022-03-01
Series:	Animals
Subjects:	minimum alveolar concentration MAC isoflurane WIN 55,212-2 rats
Online Access:	https://www.mdpi.com/2076-2615/12/7/853

Similar Items

Repeated Administration of the Cannabinoid WIN Alters the Isoflurane-Sparing Effect of Morphine and Dexmedetomidine
by: José Antonio Ibancovichi, et al.
Published: (2023-04-01)

Cannabinoid WIN55,212-2 reprograms monocytes and macrophages to inhibit LPS-induced inflammation
by: Mario Pérez-Diego, et al.
Published: (2023-03-01)

WIN 55,212-2 Inhibits the Epithelial Mesenchymal Transition of Gastric Cancer Cells via COX-2 Signals
by: Xiangshu Xian, et al.
Published: (2016-11-01)

Synthetic cannabinoid WIN 55,212–2 inhibits growth and induces cell death of oral and pancreatic stem-like/poorly differentiated tumor cells
by: Meng-Wei Ko, et al.
Published: (2022-10-01)

EFFECTS OF SYNTETIC CANNABINOID RECEPTOR LIGANDS WIN 55.212-2 AND ANANDAMID UPON IN VITRO ACTIVITY OF IMMUNOCOMPETENT CELLS
by: E. G. Lobanova
Published: (2014-07-01)

A male mouse model of WIN 55,212–2 self-administration to study cannabinoid addiction
by: María del Mar Cajiao-Manrique, et al.
Published: (2023-03-01)

THC exposure during adolescence increases impulsivity-like behavior in adulthood in a WIN 55,212-2 self-administration mouse model
by: María del Mar Cajiao-Manrique, et al.
Published: (2023-05-01)

Role of Nitric Oxide in the Antipruritic Effect of WIN 55,212-2, a Cannabinoid Agonist
by: Oyku Zeynep Gercek, et al.
Published: (2020-07-01)

The effect of spinally administered WIN 55,212-2, a cannabinoid agonist, on thermal pain sensitivity in diabetic rats
by: Samane Jahanabadi, et al.
Published: (2016-04-01)

WIN 55,212-2 shows anti-inflammatory and survival properties in human iPSC-derived cardiomyocytes infected with SARS-CoV-2
by: Luiz Guilherme H. S. Aragão, et al.
Published: (2021-10-01)

Consequences of Adolescent Exposure to the Cannabinoid Receptor Agonist WIN55,212-2 on Working Memory in Female Rats
by: Erin K. Kirschmann, et al.
Published: (2017-07-01)

Involvement of the CB2 cannabinoid receptor in cell growth inhibition and G0/G1 cell cycle arrest via the cannabinoid agonist WIN 55,212–2 in renal cell carcinoma
by: Mohammed I. Khan, et al.
Published: (2018-05-01)

The Neuroprotective Effect of Cannabinoid Receptor Agonist (WIN55,212-2) in Paraoxon Induced Neurotoxicity in PC12 Cells and N-methyl-D-aspartate Receptor Interaction
by: Hedayat Sahraei, et al.
Published: (2010-01-01)

WIN55,212-2, a Dual Modulator of Cannabinoid Receptors and G Protein-Coupled Inward Rectifier Potassium Channels
by: Dongchen An, et al.
Published: (2021-04-01)

WIN55,212-2 Attenuates Cognitive Impairments in AlCl<sub>3</sub> + <span style="font-variant: small-caps">d</span>-Galactose-Induced Alzheimer’s Disease Rats by Enhancing Neurogenesis and Reversing Oxidative Stress
by: Onesimus Mahdi, et al.
Published: (2021-09-01)

The Effect of Dorsal Hippocampal α2-Adrenegic Receptors on WIN55,212-2 State-Dependent Memory of Passive Avoidance
by: M Piri, et al.
Published: (2010-09-01)

The Effect of Dorsal Hippocampal α2-Adrenegic Receptors on WIN55,212-2 State-Dependent Memory of Passive Avoidance
by: Zarrindast M.R., et al.
Published: (2010-09-01)

The Study of Destructive Effects of Exposure to WIN 55212-2, an Agonist of Cannabinoid Receptor, during Pregnancy on CNS Function of Rats’ Offspring
by: Mohammad Shabani, et al.
Published: (2011-08-01)

Effect of WIN55-212-2 and Consequences of Extinction Training on Conditioned Fear Memory in PTSD Male Rats
by: Malihe Ghasemi, et al.
Published: (2017-11-01)

Behavioral, biochemical and histopathological toxic profiles induced by sub-chronic cannabimimetic WIN55, 212–2 administration in mice
by: Ghada A. Omran, et al.
Published: (2023-02-01)

Cannabinoids: Well-Suited Candidates for the Treatment of Perinatal Brain Injury
by: José Martínez-Orgado, et al.
Published: (2013-07-01)

Influence of intracerebral administration of L-NAME in dorsal hippocampus (CA1) on WIN55, 212-2 induced state-dependent memory in the step-down passive avoidance test
by: Mohammad Nasehi, et al.
Published: (2009-01-01)

Lithium Attenuates Cannabinoid-Induced Dependence in the Animal Model: Involvement of Phosphorylated ERK1/2 and GSK-3β Signaling Pathways
by: Hamid Reza Rahimi, et al.
Published: (2014-09-01)

Effect of oral administration of gabapentin on the minimum alveolar concentration of isoflurane in cats
by: Hangbin Chen, et al.
Published: (2023-02-01)

CB1 and CB2 cannabinoids receptors regulate basal salivation and protein-electrolyte saliva content via modulation of ATPase systems functioning in the acinar cells from submandibular salivary gland
by: O. Netsyk, et al.
Published: (2010-09-01)

A MALE MOUSE MODEL OF WIN 55,212-2 SELF-ADMINISTRATION TO STUDY CANNABINOID ADDICTION
by: María Del Mar Cajiao-Manrique, et al.
Published: (2023-10-01)

Microinjection of WIN55,212-2 as a Cannabinoid Agonist into the Basolateral Amygdala Induces Sensitization to Morphine in Rats
by: Marzieh Molaei, et al.
Published: (2014-11-01)

The cannabinoid WIN55,212-2 protects against oxidized LDL-induced inflammatory response in murine macrophages[S]
by: Ming-xiu Hao, et al.
Published: (2010-08-01)

Fuzzy Win-Win: A Novel Approach to Quantify Win-Win Using Fuzzy Logic
by: Ghada A. Altarawneh, et al.
Published: (2022-03-01)

WIN 55,212-2, agonist of cannabinoid receptors, prevents amyloid β1-42 effects on astrocytes in primary culture.
by: Diana Aguirre-Rueda, et al.
Published: (2015-01-01)

Comparison of anaesthetic effects of intravenous emulsified isoflurane and inhaled isoflurane in dogs
by: Jing DONG, et al.
Published: (2020-08-01)

Use of MIRUS™ for MAC-driven application of isoflurane, sevoflurane, and desflurane in postoperative ICU patients: a randomized controlled trial
by: Martin Bellgardt, et al.
Published: (2019-10-01)

Post-status epilepticus treatment with the cannabinoid agonist WIN 55,212-2 prevents chronic epileptic hippocampal damage in rats
by: Roberto Di Maio, et al.
Published: (2015-01-01)

A Modeling Approach for Getting to Win-Win in Industrial Collaboration under Strategic Coopetition
by: Vik Pant, et al.
Published: (2019-07-01)

A Note on Some Weaker Notions of Cop-Win and Robber-Win Graphs
by: Shravan Luckraz, et al.
Published: (2022-11-01)

A jednak win-win: pragmatyka etyki przedsiębiorczości, czyli nowe spojrzenie na negocjacje
by: Paweł J. Dąbrowski
Published: (2008-01-01)

Cause-related marketing as a win-win strategy
by: Raletić Saša, et al.
Published: (2010-01-01)

Development and Validation of the Win-Win Scale
by: Shan Zhang, et al.
Published: (2021-05-01)

Corrigendum: Development and Validation of the Win-Win Scale
by: Shan Zhang, et al.
Published: (2021-08-01)

Clinical Evalualtion in Isoflurane and Sevoflurane Anesthesia in Rat
by: Flavia Ruxanda, et al.
Published: (2016-07-01)